Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Oriana H.Y. Yu"'
Autor:
Laurent Azoulay, Elisabetta Patorno, Sebastian Schneeweiss, Robert W. Platt, Lysanne Campeau, Oriana H.Y. Yu, Blanaid Hicks, Seanna Vine, Huimin Yin, Helen Tesfaye, Devin Abrahami
Objective: To determine whether sodium-glucose co-transporter 2 (SGLT2) inhibitors, compared with glucagon-like peptide-receptor agonists (GLP-1RAs) or dipeptidyl peptidase-4 (DPP4) inhibitors are associated with an increased risk of early bladder ca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8719f0d5295affe61d83425d37bdaee2
https://doi.org/10.2337/figshare.21040987
https://doi.org/10.2337/figshare.21040987
ObjectiveTo determine whether the use of sodium-glucose cotransporter 2 (SGLT-2) inhibitors, compared to dipeptidyl peptidase 4 (DPP-4) inhibitors, is associated with a decreased risk of incident lung cancers among patients with type 2 diabetes.Metho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0b16435d26ee3815587b6f8ff402f56e
https://doi.org/10.1101/2022.08.09.22278566
https://doi.org/10.1101/2022.08.09.22278566
Publikováno v:
Diabetes care. 45(10)
OBJECTIVE To determine whether the use of dipeptidyl peptidase 4 (DPP-4) inhibitors and glucagon-like peptide 1 receptor agonists (GLP-1 RAs), separately, is associated with an increased risk of acute liver injury compared with the use of sodium–gl